Pathway involving the N155H mutation in HIV-1 integrase leads to dolutegravir resistance
出版年份 2018 全文链接
标题
Pathway involving the N155H mutation in HIV-1 integrase leads to dolutegravir resistance
作者
关键词
-
出版物
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 73, Issue 5, Pages 1158-1166
出版商
Oxford University Press (OUP)
发表日期
2017-12-22
DOI
10.1093/jac/dkx529
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Combination of two pathways involved in raltegravir resistance confers dolutegravir resistance
- (2015) Isabelle Malet et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Integrase inhibitor reversal dynamics indicate unintegrated HIV-1 dna initiate de novo integration
- (2015) Sylvain Thierry et al. Retrovirology
- Dolutegravir versus placebo in subjects harbouring HIV-1 with integrase inhibitor resistance associated substitutions: 48-week results from VIKING-4, a randomized study
- (2014) Bisher Akil et al. ANTIVIRAL THERAPY
- G118R and F121Y mutations identified in patients failing raltegravir treatment confer dolutegravir resistance
- (2014) Soundasse Munir et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- New raltegravir resistance pathways induce broad cross-resistance to all currently used integrase inhibitors
- (2014) I. Malet et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study
- (2014) A. Castagna et al. JOURNAL OF INFECTIOUS DISEASES
- In vitro phenotypes to elvitegravir and dolutegravir in primary macrophages and lymphocytes of clonal recombinant viral variants selected in patients failing raltegravir
- (2013) F. Canducci et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Quantitative analysis of the time-course of viral DNA forms during the HIV-1 life cycle
- (2013) Soundasse Munir et al. Retrovirology
- Broad Phenotypic Cross-Resistance to Elvitegravir in HIV-Infected Patients Failing on Raltegravir-Containing Regimens
- (2012) Carolina Garrido et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety and Efficacy of Dolutegravir in Treatment-Experienced Subjects With Raltegravir-Resistant HIV Type 1 Infection: 24-Week Results of the VIKING Study
- (2012) Joseph J. Eron et al. JOURNAL OF INFECTIOUS DISEASES
- The structural biology of HIV-1: mechanistic and therapeutic insights
- (2012) Alan Engelman et al. NATURE REVIEWS MICROBIOLOGY
- Dolutegravir (S/GSK1349572) Exhibits Significantly Slower Dissociation than Raltegravir and Elvitegravir from Wild-Type and Integrase Inhibitor-Resistant HIV-1 Integrase-DNA Complexes
- (2011) Kendra E. Hightower et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Characterization of the R263K Mutation in HIV-1 Integrase That Confers Low-Level Resistance to the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir
- (2011) P. K. Quashie et al. JOURNAL OF VIROLOGY
- Structural and Functional Analyses of the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir (S/GSK1349572)
- (2011) S. Hare et al. MOLECULAR PHARMACOLOGY
- In VitroAntiretroviral Properties of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor
- (2010) Masanori Kobayashi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Retroviral intasome assembly and inhibition of DNA strand transfer
- (2010) Stephen Hare et al. NATURE
- Structure-based modeling of the functional HIV-1 intasome and its inhibition
- (2010) L. Krishnan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mutations Associated with Failure of Raltegravir Treatment Affect Integrase Sensitivity to the Inhibitor In Vitro
- (2008) I. Malet et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Terminal (Catalytic) Adenosine of the HIV LTR Controls the Kinetics of Binding and Dissociation of HIV Integrase Strand Transfer Inhibitors
- (2008) David R. Langley et al. BIOCHEMISTRY
- Drug resistance profiles for the HIV integrase gene in patients failing raltegravir salvage therapy*
- (2008) C Charpentier et al. HIV MEDICINE
- Resistance Mutations in Human Immunodeficiency Virus Type 1 Integrase Selected with Elvitegravir Confer Reduced Susceptibility to a Wide Range of Integrase Inhibitors
- (2008) O. Goethals et al. JOURNAL OF VIROLOGY
- Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection
- (2008) David A. Cooper et al. NEW ENGLAND JOURNAL OF MEDICINE
- Functional and structural characterization of the integrase from the prototype foamy virus
- (2008) Eugene Valkov et al. NUCLEIC ACIDS RESEARCH
- Viral complementation allows HIV-1 replication without integration
- (2008) Huub C Gelderblom et al. Retrovirology
- Integrase and integration: biochemical activities of HIV-1 integrase
- (2008) Olivier Delelis et al. Retrovirology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now